Functional and clinical impact of MYC mutations in diffuse large B cell lymphomas

MYC is a transcription factor and an oncogene that drives the pathogenesis of Burkitt lymphomas (BL) and 30–50% of diffuse large B cell lymphomas (DLBCL) (1-3). MYC protein has critical functions that profoundly impact cell fate (reviewed) (4).